IMvigor130: Efficacy and safety from a phase III study of atezolizumab (atezo) as monotherapy or combined with platinum-based chemotherapy (PBC) vs placebo plus PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)
Journal article published in 2019 by
E. Grande,
M. Galsky,
J. A. Arranz Arija,
M. De Santis,
I. D. Davis,
U. F. F. De Giorgi,
M. Mencinger,
E. Kikuchi,
X. Garcia del Muro,
M. Gumus,
M. Ozguroglu 
,
A. Rezazadeh Kalebasty,
S. H. Park,
B. Y. Alekseev,
F. A. B. Schutz
and other authors.
,
A. Rezazadeh Kalebasty,
S. H. Park,
B. Y. Alekseev,
F. A. B. Schutz
and other authors.
